Drug Patent List
Litigation OpportunitiesNew
Newsletter
Weekly Digest

Pharsight

Metoprolol Succinate Patent Expiration

Metoprolol Succinate was first introduced by Toprol Acquisition Llc in its drug Toprol-Xl on Jan 10, 1992. Another drug containing Metoprolol Succinate is Kapspargo Sprinkle. 26 different companies have introduced drugs containing Metoprolol Succinate.


Metoprolol Succinate Patents

Given below is the list of patents protecting Metoprolol Succinate, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Kapspargo Sprinkle US9504655 Capsule dosage form of metoprolol succinate Jul 09, 2035 Spil
Kapspargo Sprinkle US9700530 Capsule dosage form of metoprolol succinate Jul 09, 2035 Spil



Metoprolol Succinate's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Metoprolol Succinate Generic API Manufacturers

Several generic applications have been filed for Metoprolol Succinate. The first generic version for Metoprolol Succinate was by Sandoz and was approved on Jul 31, 2006. And the latest generic version is by Ipca Laboratories Ltd and was approved on Jun 25, 2025.

Given below is the list of companies who have filed for Metoprolol Succinate generic, along with the locations of their manufacturing plants worldwide.